NRBO - NeuroBo Phase 2a study for MASH drug to proceed as planned
2024-03-13 11:06:04 ET
More on NeuroBo Pharmaceuticals
- NeuroBo stock jumps 14% on weight-loss drug update
- NeuroBo to begin Phase 1 testing of potential Wegovy rival
- Seeking Alpha’s Quant Rating on NeuroBo Pharmaceuticals
- Historical earnings data for NeuroBo Pharmaceuticals
- Financial information for NeuroBo Pharmaceuticals